Show simple item record

dc.contributor.authorFadnes, Lars Thoreen_US
dc.contributor.authorNankabirwa, Victoriaen_US
dc.contributor.authorSommerfelt, Halvoren_US
dc.contributor.authorTylleskär, Thorkilden_US
dc.contributor.authorTumwine, James K.en_US
dc.contributor.authorEngebretsen, Ingunn Marie S.en_US
dc.description.abstractBackground: Timely vaccination is important to protect children from common infectious diseases. We assessed vaccination timeliness and vaccination coverage as well as coverage of vitamin A supplementation in a Ugandan setting. Methods and findings: This study used vaccination information gathered during a cluster-randomized trial promoting exclusive breastfeeding in Eastern Uganda between 2006 and 2008 ( no. NCT00397150). Five visits were carried out from birth up to 2 years of age (median follow-up time 1.5 years), and 765 children were included in the analysis. We used Kaplan–Meier time-to-event analysis to describe vaccination coverage and timeliness. Vaccination coverage at the end of follow-up was above 90% for all vaccines assessed individually that were part of the Expanded Program on Immunization (EPI), except for the measles vaccine which had 80% coverage (95%CI 76–83). In total, 75% (95%CI 71–79) had received all the recommended vaccines at the end of follow-up. Timely vaccination according to the recommendations of the Ugandan EPI was less common, ranging from 56% for the measles vaccine (95%CI 54–57) to 89% for the Bacillus Calmette–Guérin (BCG) vaccine (95%CI 86–91). Only 18% of the children received all vaccines within the recommended time ranges (95%CI 15–22). The children of mothers with higher education had more timely vaccination. The coverage for vitamin A supplementation at end of follow-up was 84% (95%CI 81–87). Conclusions: Vaccination coverage was reasonably high, but often not timely. Many children were unprotected for several months despite being vaccinated at the end of follow-up. There is a need for continued efforts to optimise vaccination timeliness.en_US
dc.rightsAttribution-NonCommercial-NoDerivs CC BY-NC-NDeng
dc.subjectMass vaccinationeng
dc.subjectVaccination timelinesseng
dc.subjectVaccination coverageeng
dc.subjectSub-Saharan Africaeng
dc.titleIs vaccination coverage a good indicator of age-appropriate vaccination? A prospective study from Ugandaen_US
dc.typePeer reviewed
dc.typeJournal article
dc.rights.holderCopyright 2011 Elsevier Ltd.
dc.subject.nsiVDP::Medical sciences: 700::Health sciences: 800::Preventive medicine: 804eng
dc.subject.nsiVDP::Medisinske fag: 700::Helsefag: 800::Forebyggende medisin: 804nob

Files in this item


This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs CC BY-NC-ND
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs CC BY-NC-ND